2Company · Healthtech & Bio
2EyesVision
Madrid-based ophthalmic medtech company, spun off from the Spanish National Research Council (CSIC) in 2015, that develops SimVis Gekko, a wearable binocular visual simulator letting patients preview presbyopia and cataract vision corrections (IOLs, trifocals, EDOF lenses, contact lenses) before surgery. Backed by Bullnet Capital, CDTI/INNVIERTE and Luminate, the company sells internationally across 18 countries and holds 8 patent families.
Founded
2015
Founders
2
News
7
Rounds
2
Investors
4
SectorsHealthtech & Bio, Medical Devices, Ophthalmology, Optics
Start-up MapHealthtech & Bio › Medical devices & surgical hardware
Profile updated 19 Jul 2026
Founders
C
Carlos Dorronsoro Díaz
CEO & Co-Founder
S
Susana Marcos
Co-Founder
Global models 5
R
RxSight
United States · www.rxsight.com ↗
VC-backed maker of light-adjustable intraocular lens technology that lets surgeons customize post-cataract-surgery vision correction, addressing the same presbyopia/cataract-correction workflow.
$194MComparable
AcuFocus
United States · acufocus.com ↗
VC-backed developer of small-aperture IOL and corneal inlay technology for presbyopia correction, targeting the same cataract/presbyopia surgical-outcome market.
~$200MComparable
L
LensGen
United States · lensgen.com ↗
VC-funded developer of accommodating (fluid-based) intraocular lenses restoring natural focus after cataract surgery, same presbyopia-correction IOL space.
~$90MComparable
Presbia
United States/Netherlands · www.presbia.com ↗
VC-backed developer of a corneal microlens implant (Presbia Flexivue Microlens) to correct presbyopia, competing in the same surgical vision-correction niche.
~$150MComparable
VVivior AG
Switzerland · www.vivior.com ↗
VC-backed maker of a wearable lifestyle-monitoring device used to personalize IOL selection before cataract surgery — the closest business-model match as a pre-surgical decision-support device rather than the implant itself.
~$15MComparable
Investors 4
Funding rounds 2
News & media 7
| Published | Article |
|---|---|
| 2026-07-16 |
CDTI Innvierte destina en junio €96M a 7 nuevas coinversiones en capital riesgo y 1 vehículo de inversión ↗
Webcapitalriesgo
|
| 2026-04-14 |
2EyesVision Launches SimVis Academy to Support Clinical Adoption of Preoperative Visual Simulation ↗
2EyesVision (press release)
|
| 2026-02-11 |
Vision Simulators ↗
CRSToday
|
| 2025-10-29 |
2EyesVision, backed by Bullnet and CDTI, launches a €1 million funding round with the support of Capital Cell ↗
Capital-Riesgo.es
|
| 2025-08-08 |
Carlos Dorronsoro, de 2EyesVision: "Nuestra propuesta no es solo innovadora, es clínicamente relevante" ↗
MuyPymes
|
| 2025-06-30 |
2EyesVision launches SimVis Gekko2, the visual simulator ↗
2EyesVision (press release)
|
| 2025-04-30 |
2EyesVision Boosts Global Expansion with €2 Million Capital Injection ↗
Empresa Exterior
|



